Siemens Partners with Clean Power Hydrogen; Grifols Plans IPO Amid Debt Concerns

Siemens PLC has announced a partnership with Clean Power Hydrogen to support the industrial production of membrane-free electrolysis technology. Grifols, a Spanish blood plasma specialist, saw a 6% increase in stock after announcing an IPO for a minority stake in its U.S. biopharmaceutical division, interpreted as a step toward reducing its estimated €8 billion net debt. Other notable movements include Nanobiotix's stock rising by 10% due to potential acquisition interest from Johnson & Johnson.

Published Mar 26, 2026

Siemens PLC has partnered with Clean Power Hydrogen to provide technical and operational support for the industrial production of membrane-free electrolysis technology. Grifols, a Spanish company specializing in blood plasma-derived medications, experienced a 6% stock increase following the announcement of an IPO for a minority stake in its U.S. biopharma division, viewed as a sign of deleveraging amid an estimated €8 billion net debt.

AI-curated by Theia

Nanobiotix's shares rose by 10% amid reports of Johnson & Johnson considering a takeover. Other stocks impacted include Swedbank, trading ex-dividend, and RS Group, which downgraded its growth forecast.